Corient Private Wealth
MEDP icon

Corient Private Wealth’s Medpace MEDP Stock Holding History

Corient Private Wealth’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$773K Sell
1,613
-1,842
-53% -$943K ﹤0.01% 1790
2025
Q4 		$1.93M Buy
3,455
+1,745
+102% +$991K ﹤0.01% 1544
2025
Q3 		$879K Sell
1,710
-2,699
-61% -$1.18M ﹤0.01% 1490
2025
Q2 		$1.38M Buy
4,409
+1,415
+47% +$425K ﹤0.01% 1209
2025
Q1 		$912K Buy
2,994
+614
+26% +$207K ﹤0.01% 1315
2024
Q4 		$791K Buy
2,380
+1,101
+86% +$373K ﹤0.01% 1414
2024
Q3 		$427K Sell
1,279
-164
-11% -$62.3K ﹤0.01% 1825
2024
Q2 		$594K Buy
1,443
+507
+54% +$201K ﹤0.01% 1555
2024
Q1 		$378K Buy
936
+20
+2% +$7.03K ﹤0.01% 1773
2023
Q4 		$281K Buy
+916
New +$247K ﹤0.01% 1894

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Corient Private Wealth's MEDP Position: Q1 2026 in Review

Corient Private Wealth reduced its Medpace (MEDP) stake by 53% in Q1 2026, selling an estimated $943K and leaving 1,613 shares worth $773K. The position accounts for ﹤0.01% of the portfolio, ranked #1790.

Corient Private Wealth first reported a position in MEDP in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.93M in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Corient Private Wealth held 1,613 shares of Medpace worth $773K as of Q1 2026.
  • Corient Private Wealth sold 1,842 Medpace shares in Q1 2026, an estimated $943K.
  • Medpace made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #1790 holding.
  • Corient Private Wealth first reported a position in Medpace in Q4 2023 and has held it in 10 quarters since.
  • Corient Private Wealth's Medpace position peaked at $1.93M in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.